Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Sensitive

Esophageal squamous cell carcinoma

PLCE1 · rs7099485

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−8, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 1,686 Sub-Saharan African ancestry cases, 3,217 Sub-Saharan African ancestry controls, 2,013 East Asian ancestry cases, 2,701 East Asian ancestry controls.

The effect Each copy of the C allele carried 1.94 times the odds of Esophageal squamous cell carcinoma (95% confidence interval 1.86-2.03); p = 1 × 10−8.

Where it sits Chromosome 10, band 10q23.33 — in an intron of PLCE1.

How common each version is

CT
Korean KRGDB
C 25.0% · T 75.0%
Korean Korea4K
C 26.1% · T 73.9%
Korean Korea1K
C 26.2% · T 73.9%
Japanese ToMMo
C 24.7% · T 75.3%
World gnomAD
C 33.5% · T 66.5%
World 1000 Genomes
C 32.2% · T 67.8%
World TOPMed
C 34.1% · T 65.9%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study.

What each result means

C/C Two copies of the version the research linked to Esophageal squamous cell carcinoma. That is the strongest link of the three results. A link in a study is not a diagnosis.
C/T One copy of the version the research linked to Esophageal squamous cell carcinoma. That is a smaller link than two copies.
T/T No copy of the version the research linked to Esophageal squamous cell carcinoma. This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Esophageal squamous cell carcinoma (rs7099485). MyGeneLog™. https://www.mygenelog.com/variants/rs7099485

← See all variants